Citizens Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.54M Buy
75,424
+2,083
+3% +$200K 0.09% 154
2025
Q4
$7.05M Buy
73,341
+2,413
+3% +$234K 0.09% 156
2025
Q3
$6.76M Buy
70,928
+40,625
+134% +$3.73M 0.09% 163
2025
Q2
$2.64M Buy
30,303
+15,307
+102% +$1.3M 0.04% 225
2025
Q1
$1.36M Buy
14,996
+860
+6% +$77K 0.03% 277
2024
Q4
$1.13M Sell
14,136
-1,737
-11% -$150K 0.02% 283
2024
Q3
$1.44M Buy
15,873
+3,805
+32% +$320K 0.03% 252
2024
Q2
$950K Buy
12,068
+8,550
+243% +$701K 0.02% 277
2024
Q1
$307K Buy
3,518
+470
+15% +$40.1K 0.01% 332
2023
Q4
$251K Sell
3,048
-3,626
-54% -$276K 0.01% 358
2023
Q3
$523K Sell
6,674
-2,924
-30% -$245K 0.02% 238
2023
Q2
$846K Sell
9,598
-3,980
-29% -$343K 0.03% 225
2023
Q1
$1.1M Sell
13,578
-63
-0.5% -$5.13K 0.04% 213
2022
Q4
$1.07M Sell
13,641
-806
-6% -$65.3K 0.04% 194
2022
Q3
$1.17M Buy
14,447
+286
+2% +$25.7K 0.05% 175
2022
Q2
$1.28M Sell
14,161
-2,462
-15% -$249K 0.05% 170
2022
Q1
$1.85M Buy
16,623
+1,622
+11% +$171K 0.06% 157
2021
Q4
$1.56M Sell
15,001
-2,046
-12% -$237K 0.05% 175
2021
Q3
$2.14M Buy
17,047
+8,556
+101% +$1.11M 0.08% 150
2021
Q2
$1.05M Buy
8,491
+2,211
+35% +$278K 0.05% 171
2021
Q1
$742K Buy
6,280
+1,710
+37% +$200K 0.04% 176
2020
Q4
$535K Sell
4,570
-159
-3% -$17.5K 0.03% 188
2020
Q3
$491K Sell
4,729
-681
-13% -$68.4K 0.03% 181
2020
Q2
$497K Sell
5,410
-690
-11% -$66.2K 0.03% 188
2020
Q1
$551K Sell
6,100
-679
-10% -$72.2K 0.05% 176
2019
Q4
$769K Buy
6,779
+841
+14% +$92.3K 0.05% 159
2019
Q3
$645K Buy
5,938
+223
+4% +$23.3K 0.05% 156
2019
Q2
$557K Sell
5,715
-114
-2% -$10.4K 0.04% 164
2019
Q1
$531K Buy
5,829
+753
+15% +$67.4K 0.04% 167
2018
Q4
$461K Buy
5,076
+827
+19% +$77.3K 0.04% 156
2018
Q3
$418K Sell
4,249
-215
-5% -$19.9K 0.03% 171
2018
Q2
$382K Sell
4,464
-888
-17% -$74.2K 0.03% 178
2018
Q1
$429K Buy
5,352
+1,941
+57% +$160K 0.04% 174
2017
Q4
$275K Sell
3,411
-1,304
-28% -$104K 0.02% 201
2017
Q3
$367K Sell
4,715
-171
-3% -$14.2K 0.03% 181
2017
Q2
$434K Buy
4,886
+448
+10% +$37.8K 0.04% 175
2017
Q1
$358K Sell
4,438
-848
-16% -$66.2K 0.03% 183
2016
Q4
$377K Sell
5,286
-21
-0.4% -$1.65K 0.04% 179
2016
Q3
$459K Hold
5,307
0.04% 164
2016
Q2
$460K Sell
5,307
-454
-8% -$36.7K 0.04% 170
2016
Q1
$432K Sell
5,761
-2,221
-28% -$167K 0.04% 172
2015
Q4
$645K Buy
+7,982
New +$601K 0.06% 143

Other funds holding MDT

Citizens Financial Group's MDT Position: Q1 2026 in Review

Citizens Financial Group increased its Medtronic (MDT) stake by 2.8% in Q1 2026, buying an estimated $200K and bringing the position to 75,424 shares worth $6.54M. The position accounts for 0.09% of the portfolio, ranked #154.

Citizens Financial Group first reported a position in MDT in Q4 2015 and has held it in 42 quarters since. The position peaked at $7.05M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Citizens Financial Group held 75,424 shares of Medtronic worth $6.54M as of Q1 2026.
  • Citizens Financial Group bought 2,083 Medtronic shares in Q1 2026, an estimated $200K.
  • Medtronic made up 0.09% of Citizens Financial Group's portfolio in Q1 2026, its #154 holding.
  • Citizens Financial Group first reported a position in Medtronic in Q4 2015 and has held it in 42 quarters since.
  • Citizens Financial Group's Medtronic position peaked at $7.05M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.